Cancer News and Research

Latest Cancer News and Research

Exercise is emerging as a new therapeutic weapon to tackle cancer

When individuals with breast or prostate cancer followed a moderate, home-based exercise program using resistance bands and walking, the patients had less fatigue during radiation treatments, greater strength and could walk farther and faster in only four weeks, researchers discovered in a pilot study.

7 Jun 2006

Gene mutation potentially involved in breast cancer initiation

Researchers have found evidence suggesting that a mutation in a gene that normally helps block the formation of breast tumors could play a role in the initiation of a major form of breast cancer.

6 Jun 2006

Impact of obesity on treatment of chronic hepatitis C

According to a new study, obese patients chronically infected with the hepatitis C virus (HCV) and treated with combination drug therapy may have better outcomes if the underlying abnormalities caused by excessive fat tissue are corrected.

6 Jun 2006

Long-term benefits of imatinib for patients newly diagnosed with chronic myelogenous leukemia

The overall survival of most people with chronic myelogenous leukemia (CML) treated with imatinib (Gleevec, STI-571) is extremely high and the relapse rate is quite low, according to new data from a study out of the Oregon Health & Science University Cancer Institute.

6 Jun 2006

Evidence is strong that green tea lowers the risk for a number of chronic diseases

There is a lower incidence of cardiovascular disease and cancer in Asia where people smoke heavily, which may be accounted for by high consumption of tea, particularly green tea, according to a review article published by a Yale School of Medicine researcher.

6 Jun 2006

Calpain protein key to preventing or promoting cell death

A protein called calpain can be the key either preventing or promoting the cell death, a Queen's University study has found.

6 Jun 2006

Hormonal treatments reduce risk of cancer returning

Women diagnosed with breast cancer who carry a certain genetic mutation can have breast-sparing surgery but should consider hormonal treatments to reduce their risk of cancer returning.

6 Jun 2006

Better understanding of DNA damage

Researchers have known for years that damaged DNA can lead to human diseases such as cancer, but how damage occurs - and what causes it - has remained less clear.

6 Jun 2006

New procedures to help decide which breast cancer patients will benefit most from radiotherapy

New procedures which will help doctors decide which breast cancer patients will benefit most from radiotherapy begin trials this week.

6 Jun 2006

Novel research points to promising relief target for chronic pain

By some accounts, chronic pain affects nearly 100 million Americans from such varied causes as arthritis, sciatica, cancer, diabetes. Most forms of pain result from identifiable causes which serve the "good" purpose in warning of a real physical problem that needs attention, or rest.

6 Jun 2006

Researchers show that different forms of amyloid beta lead to neural damage in different ways

Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.

6 Jun 2006

New findings offer hope for vaccine against AIDS

AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought.

6 Jun 2006

Researchers discover the presence of the genetic material RNA in the centrosome

Researchers have discovered the presence of the genetic material RNA in the centrosome, the organizing structure inside each cell that assures proper cell division.

6 Jun 2006

Drug adverts aimed at cancer patients difficult to read

Oncology drug advertisements that ran in patient-focused cancer magazines presented the drugs' benefits differently -- earlier in the advertisement text and in larger type size -- than their side effects or risks, according to an analysis by researchers at Dana-Farber Cancer Institute in Boston.

6 Jun 2006